These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India. Ahmed S, Shukla I, Fatima N, Varshney SK, Shameem M, Tayyaba U. Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028 [Abstract] [Full Text] [Related]
25. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India. Khurana P, Saigal K, Ghosh A. Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317 [Abstract] [Full Text] [Related]
26. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study. Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE. PLoS One; 2012 Oct; 7(11):e49898. PubMed ID: 23226229 [Abstract] [Full Text] [Related]
27. A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens. Raizada N, Sachdeva KS, Chauhan DS, Malhotra B, Reddy K, Dave PV, Mundade Y, Patel P, Ramachandran R, Das R, Solanki R, Wares DF, Sahu S, O'Brien R, Paramasivan CN, Dewan PK. PLoS One; 2014 Oct; 9(2):e88626. PubMed ID: 24586360 [Abstract] [Full Text] [Related]
28. Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR-TB test. Ramasubban G, Michael JS, Gupta R, Venkatesan M, Beauton AP, Hoffner S, Asalapuram P. Int J Mycobacteriol; 2024 Jan 01; 13(1):91-95. PubMed ID: 38771285 [Abstract] [Full Text] [Related]
31. [Molecular test Genotype® MTBDRplus, an alternative to rapid detection of multidrug resistance tuberculosis]. Asencios L, Galarza M, Quispe N, Vásquez L, Leo E, Valencia E, Ramírez J, Acurio M, Salazar R, Mendoza-Ticona A, Cáceres O. Rev Peru Med Exp Salud Publica; 2012 Mar 01; 29(1):92-8. PubMed ID: 22510913 [Abstract] [Full Text] [Related]
33. Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys. Rigouts L, Hoza AS, De Rijk P, Torrea G, Chonde TM, Basra D, Zignol M, van Leth F, Egwaga SM, Van Deun A. Int J Tuberc Lung Dis; 2011 Jul 01; 15(7):959-65. PubMed ID: 21682972 [Abstract] [Full Text] [Related]
36. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Am J Respir Crit Care Med; 2008 Apr 01; 177(7):787-92. PubMed ID: 18202343 [Abstract] [Full Text] [Related]
38. Evaluation of genotype MTBDRplus assay for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis clinical isolates from Pakistan. Javed H, Jamil N, Jagielski T, Bakuła Z, Tahir Z. Int J Mycobacteriol; 2016 Dec 01; 5 Suppl 1():S147-S148. PubMed ID: 28043516 [Abstract] [Full Text] [Related]
39. Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana. Asante-Poku A, Otchere ID, Danso E, Mensah DD, Bonsu F, Gagneux S, Yeboah-Manu D. Int J Tuberc Lung Dis; 2015 Aug 01; 19(8):954-959. PubMed ID: 26162362 [Abstract] [Full Text] [Related]